Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma

Erlotinib is an oral tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR) pathway. Although our previous study has proved the efficacy of Erlotinib in head and neck squamous cell carcinoma (HNSCC), it has also demonstrated poor clinical response rates and disappointing results in cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Commun Signal
Main Authors: Zheng, Yang, Song, An, Zhou, Yan, Zhong, Yi, Zhang, Wei, Wang, Chundi, Ding, Xu, Du, Yifei, Li, Gang, Wu, Heming, Wu, Yunong, Song, Xiaomeng
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Netherlands 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7642164/
https://ncbi.nlm.nih.gov/pubmed/32157550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-020-00546-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados